Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | bromodomain adjacent to zinc finger domain, 2B | Starlite/ChEMBL | No references |
Homo sapiens | EYA transcriptional coactivator and phosphatase 2 | Starlite/ChEMBL | No references |
Homo sapiens | glucagon-like peptide 1 receptor | Starlite/ChEMBL | No references |
Homo sapiens | glutaminase | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Loa Loa (eye worm) | pigment dispersing factor receptor c | glucagon-like peptide 1 receptor | 463 aa | 388 aa | 25.8 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | hypothetical protein | 0.0085 | 0.2015 | 0.1982 |
Loa Loa (eye worm) | hypothetical protein | 0.0049 | 0.0834 | 0.0795 |
Schistosoma mansoni | hypothetical protein | 0.0025 | 0.0042 | 0.0042 |
Echinococcus multilocularis | fetal alzheimer antigen, falz | 0.0027 | 0.0117 | 0.0739 |
Loa Loa (eye worm) | hypothetical protein | 0.0106 | 0.2701 | 0.267 |
Schistosoma mansoni | acetyl-CoA C-acetyltransferase | 0.0027 | 0.0117 | 0.0117 |
Echinococcus granulosus | fetal alzheimer antigen falz | 0.0027 | 0.0117 | 0.0739 |
Mycobacterium ulcerans | glutaminase | 0.033 | 1 | 0.5 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.006 | 0.1193 | 0.1004 |
Echinococcus granulosus | bromodomain adjacent to zinc finger domain | 0.0043 | 0.0644 | 0.4076 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.006 | 0.1193 | 0.1156 |
Loa Loa (eye worm) | glutaminase 2 | 0.033 | 1 | 1 |
Trichomonas vaginalis | glutaminase, putative | 0.033 | 1 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0052 | 0.0909 | 0.0871 |
Loa Loa (eye worm) | hypothetical protein | 0.0106 | 0.2701 | 0.267 |
Schistosoma mansoni | hypothetical protein | 0.0041 | 0.0571 | 0.0571 |
Echinococcus multilocularis | bromodomain adjacent to zinc finger domain | 0.0043 | 0.0644 | 0.4076 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0041 | 0.0571 | 0.0369 |
Loa Loa (eye worm) | hypothetical protein | 0.0041 | 0.0571 | 0.0532 |
Schistosoma mansoni | bromodomain containing protein | 0.0076 | 0.1722 | 0.1722 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.006 | 0.1193 | 0.1004 |
Schistosoma mansoni | glutaminase | 0.033 | 1 | 1 |
Echinococcus multilocularis | bromodomain adjacent to zinc finger domain | 0.0072 | 0.1581 | 1 |
Loa Loa (eye worm) | glutaminase | 0.033 | 1 | 1 |
Echinococcus granulosus | bromodomain adjacent to zinc finger domain | 0.0072 | 0.1581 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0046 | 0.0741 | 0.0702 |
Schistosoma mansoni | eyes absent homolog | 0.0106 | 0.2701 | 0.2701 |
Brugia malayi | Bromodomain containing protein | 0.0046 | 0.0738 | 0.0539 |
Brugia malayi | Bromodomain containing protein | 0.0091 | 0.2184 | 0.2016 |
Brugia malayi | hypothetical protein | 0.0106 | 0.2701 | 0.2544 |
Loa Loa (eye worm) | hypothetical protein | 0.006 | 0.1193 | 0.1156 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 0.631 uM | PubChem BioAssay. qHTS for Inhibitors of Glutaminase (GLS). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 1.9953 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b: Cytotox Counterscreen. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588855, AID588860] | ChEMBL. | No reference |
Potency (functional) | 12.5893 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of BAZ2B. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504391] | ChEMBL. | No reference |
Potency (functional) | 15.104 uM | PubChem BioAssay. qHTS for Inhibitors of the Phosphatase Activity of Eya2: Confirmatory Assay for Cherry-picked Compounds. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 18.526 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 19.9526 uM | PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 22.3872 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of JMJD2A-Tudor Domain. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504402] | ChEMBL. | No reference |
Potency (functional) | 28.1838 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404] | ChEMBL. | No reference |
Potency (functional) | 29.081 uM | PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125] | ChEMBL. | No reference |
Potency (functional) | 50.1187 uM | PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962] | ChEMBL. | No reference |
Potency (functional) | 100 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 | ||
Homo sapiens | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.